Using the validated GRN-detecting antibodies from Sigma (GRN-2,3) and Novus (GRN-4), we first measured mature GRN levels in primary human fibroblasts from three FTD-GRN patients compared with three controls (Fig. 9A). Here, GRN is linked to frontotemporal dementia.